#United States #San Diego #EHA #Hematology #ASH

EHA Showcases Commitment to Innovation and Collaboration at ASH Annual Meeting 2024

The European Hematology Association (EHA) is set to demonstrate its commitment to innovative research and collaboration during the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from December 7-10, 2024, in the vibrant city of San Diego, California. This annual meeting serves as a vital platform for professionals in the field of hematology to connect and share groundbreaking insights.

The partnership between EHA and ASH highlights a shared dedication to enhancing patient care through improved research and education. A pivotal point of the meeting will be the EHA-ASH Joint Symposium on December 8, where experts will delve into myelodysplastic syndromes. Esteemed speakers like Amy DeZern from Johns Hopkins University and Matteo Della Porta from Humanitas Cancer Center will provide critical insights, making it a must-attend session for hematology professionals.

EHA President Antonio Almeida emphasized the significance of this collaboration, stating, "The collaboration between EHA and ASH holds immense significance for the global medical community." Almeida pointed out that the alliance serves as a cornerstone for advancing understanding, research, education, and treatment within the realm of blood disorders. He reiterated that through this synergy, both organizations are positioned to enhance research, advocacy, and ultimately, patient care, bringing about benefits that resonate globally.

In recent years, EHA has experienced remarkable growth and engagement within the hematology community. The organization reported a 25% increase in membership during 2024, which now totals over 8,300 members. This surge indicates a strong commitment to a member-focused approach that encourages professionals from around the world to exchange knowledge, collaborate on research initiatives, and share best practices. The EHA2024 Congress attracted a record-breaking 17,900 delegates, further underscoring the organization's pivotal role in the field.

EHA's peer-reviewed journal, HemaSphere, has also achieved notable milestones, boasting a 2023 Impact Factor of 11.9. This impressive figure ranks HemaSphere seventh among global hematology journals, cementing its reputation for publishing high-quality, cutting-edge research that is vital to the hematology community.

With a visionary aim of creating a "Borderless Hematology," the EHA continues to strive for global connectivity, innovation, and excellence in the field of hematology. This commitment not only strengthens the community but also enhances resources available for research and education in blood disorders.

Delegates attending the ASH meeting are encouraged to visit EHA at booth #300 to learn more about the organization’s initiatives and contributions to the field.

About EHA

Founded to support and connect medical professionals, researchers, and scientists interested in hematology, the European Hematology Association (EHA) stands as the largest organization based in Europe dedicated to the field of hematology. With over 8,000 members, EHA is committed to advocating for the needs of hematologists while promoting research development and harmonizing education within the field. EHA's mission is clear: to pave the way towards improved prevention, treatment, and overall quality of life for patients suffering from blood disorders.

For more information about EHA, visit their website at www.ehaweb.org.